Fatiga

10-Undecenoic acid (undecylenic acid) is an unsaturated fatty acid derived from castor oil with FDA-approved OTC status for superficial fungal skin infections including tinea pedis, tinea corporis, and tinea cruris. It disrupts fungal cell membranes, inhibiting growth of dermatophytes such as Trichophyton species. In vitro studies confirm activity against multiple dermatophyte species. Its therapeutic efficacy was first recognized in the 1940s for military troops.

Ajoene, an organosulfur compound derived from garlic, has been demonstrated effective in randomized clinical trials for treating tinea pedis, tinea corporis, and tinea cruris. A double-blind study published in JAAD (2000) found 1% ajoene gel achieved 100% mycological cure in tinea pedis at 60 days, comparable to 1% terbinafine. A further RCT showed ajoene 0.6% gel performed similarly to terbinafine cream for tinea corporis and tinea cruris.

In vitro studies have documented that ajwain essential oil, thymol, and carvacrol inhibit the growth of dermatophytes and other pathogenic fungi with high efficacy (72–90% inhibition of 10 tested fungal species). Traditional use of ajwain paste for skin fungal infections is also well-documented.

Allicin, the primary bioactive organosulfur compound in garlic, has demonstrated antifungal activity against Candida, Cryptococcus, Trichophyton, Epidermophyton, and Microsporum species in multiple in vitro and in vivo studies. It damages fungal cell walls and membranes and disrupts biosynthesis pathways. In combination with itraconazole and terbinafine, allicin shows synergism against Microsporum canis in tinea capitis.

P. dioica essential oil has demonstrated in vitro antifungal activity against skin-relevant pathogens including Trichophyton rubrum (a dermatomycete) and Candida albicans. This was confirmed in the Lorenzo-Leal et al. (2019, PMC) study. Traditional use for topical fungal infections is documented.

Aloe vera demonstrates documented antifungal activity against dermatophytes (Trichophyton species) and Candida species in vitro, mediated by anthraquinones (aloe-emodin, barbaloin) and a 14 kDa antifungal protein. Aloe vera gel has shown clinical efficacy against oral candidiasis. It is also used as a penetration enhancer in antifungal product formulations.

Tryptanthrin, isolated from S. cusia leaves, has been identified as the principal antifungal and antidermatophytic agent. Published literature documents its isolation and antifungal designation, providing laboratory-level evidence for this activity. Traditional use also includes external application to skin infections.

Berberine from barberry has demonstrated antifungal activity against Candida and other pathogenic fungi in multiple in vitro studies, including against fluconazole-resistant strains. Topical applications for fungal skin conditions are documented in herbal references. Clinical human trials specifically for fungal skin infections are lacking.

O. basilicum essential oil has demonstrated in vitro antifungal activity against Aspergillus flavus (inhibiting growth and aflatoxin B1), and extracts show dose-dependent antifungal activity against dermatophytes. The Herbal Reality monograph states antifungal action is specific to Tinea skin infections. Evidence is primarily in vitro.

Bee propolis has demonstrated antifungal activity against Candida species, Trichophyton, and Aspergillus in multiple peer-reviewed in vitro studies and has been evaluated in at least one bench-to-clinic study for onychomycosis. It inhibits phospholipase activity, disrupting fungal adhesion, and shows broad activity against dermatophytes responsible for tinea infections. Its active antifungal components include flavonoids, phenolic acids, and terpenoid esters.

Berberine, a natural isoquinoline alkaloid from plants such as Coptis and Berberis, has demonstrated broad-spectrum antifungal activity against Candida albicans, Cryptococcus neoformans, and Trichophyton species in vitro, with MIC values of 64–128 µg/mL. In vivo studies show berberine promoted healing in guinea pigs infected with T. mentagrophytes. Its mechanism involves CYP51 inhibition (ergosterol biosynthesis) and fungal membrane disruption.

Betel leaf extract and its isolated constituent hydroxychavicol inhibit dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Epidermophyton floccosum) responsible for common skin fungal infections such as ringworm and athlete's foot. MIC values are in the antifungal range.

Juglone from black walnut hull has demonstrated antifungal activity against dermatophytes in peer-reviewed MIC studies, with potency comparable to commercial antifungal agents. Traditional use for ringworm, tinea pedis, and other skin fungi is extensive and directly aligns with this scientific evidence.

Antifungal activity of C. crista polyphenolic fractions has been demonstrated in vitro. Antibacterial and antifungal activities of polyphenolic fractions isolated from C. crista seed coat were reported in Natural Product Research (2018).

In vitro studies demonstrate cajuput oil and its extracts inhibit Candida albicans and other fungi at low concentrations (0.4–0.6%). RxList/Natural Medicines documents traditional topical use for tinea versicolor (a fungal skin condition). Lab evidence of antifungal potency is strong, but controlled clinical trials in humans with fungal skin infections have not been published.

Calendula demonstrates documented antifungal activity in vitro against multiple species of clinical fungi including dermatophytes and Candida spp. Essential oil and petal extracts show inhibition zones comparable to fluconazole. The ESCOP monograph cites clinical evidence for vaginal candidiasis; general skin fungal support has in vitro grounding.

In vitro studies demonstrate that camphor oil has significant broad-spectrum antifungal activity, inhibiting growth of Aspergillus niger, Aspergillus flavus, and Penicillium species. A clinical case series found Vicks VapoRub (containing camphor) effective against toenail fungus (onychomycosis). The 2024 MDPI review confirms antifungal activity as a documented camphor property.

Caprylic acid, a medium-chain fatty acid from coconut oil, has in vitro and computational evidence of antifungal action against Candida species and Trichophyton by penetrating and perturbing fungal cell membranes. A 2019 study found it effective at killing Candida albicans. A PMC study (2020) demonstrated it disrupts fungal membranes via steady-state fluorescence anisotropy and is potent against Candida and Trichophyton. It also inhibits virulence factors including morphogenesis and biofilm formation.

Carvacrol, a monoterpenoid phenol and the primary active compound in oregano and thyme oils, has demonstrated potent antifungal activity against Candida species, dermatophytes, and Malassezia furfur in multiple in vitro studies. It inhibits both planktonic cells and drug-resistant Candida biofilms, and oregano essential oil (primarily carvacrol) inhibited C. albicans at 0.25 mg/mL in vitro. Its wide-spectrum antifungal activity is among the most studied of any plant-derived compound.

A. aspera leaf extracts demonstrated antifungal activity against Candida albicans in a PMC/Frontiers in Pharmacology study. Traditional use for ringworm and dandruff is also documented across multiple ethnomedical systems.

Clove essential oil and eugenol demonstrate in vitro antifungal activity against dermatophytes, Aspergillus, and Candida species causing skin infections. Multiple PMC studies establish MIC values and mechanisms including ergosterol binding and cell membrane disruption.

VCO has documented in vitro antifungal activity against dermatophytes (Trichophyton, Aspergillus, Rhizopus) and Candida. A 2023 RCT evaluated VCO as adjuvant to systemic antifungals in chronic dermatophytoses. MCFA content—lauric, capric, caprylic acids—disrupts fungal cell membranes.

Coconut oil (derived from coconut milk) has demonstrated antifungal activity against dermatophytes and Candida species in vitro, with lauric acid disrupting fungal cell membranes. A JETIR review (2023) confirmed VCO's viability as a topical antifungal against skin and nail fungal infections. Clinical human studies are limited but in vitro mechanistic evidence is robust.

Coconut oil has in vitro and one small clinical trial evidence of antifungal activity against Candida albicans in cutaneous candidiasis. Its medium-chain fatty acids, particularly lauric acid and caprylic acid, disrupt fungal cell membranes. Dietary coconut oil has been shown to reduce gastrointestinal Candida colonization in animal models and MCT oil supplementation reduced Candida colonization in a human study. It is used topically in traditional medicine across tropical regions for fungal skin conditions.

Curcumin, the principal bioactive polyphenol of turmeric (Curcuma longa), has demonstrated in vitro antifungal activity against Candida species and dermatophytes. It has been found to have antifungal effects that confirm its use alongside turmeric oil in antifungal preparations. Studies confirm its activity against C. albicans, and turmeric oil preparations containing curcumin and ar-turmerone have been validated against T. rubrum and other dermatophytes.

Elecampane's sesquiterpene lactones alantolactone and isoalantolactone have demonstrated antifungal activity in vitro against dermatophytes including Trichophyton and Microsporum species that cause skin infections, as well as against Candida species. Evidence is entirely in vitro.

Eucalyptus essential oil demonstrates in vitro antifungal activity against dermatophytes (Trichophyton spp., Microsporum spp.) responsible for skin fungal infections, with 1,8-cineole identified as the primary active component disrupting fungal cell membranes. A prospective in vivo study monitored eucalyptus oil for onychomycosis. Evidence is strongest from in vitro and pilot clinical data.

Garlic (Allium sativum) and its active compounds (allicin, ajoene, diallyl sulfides) have been validated for antifungal activity against dermatophytes, Candida, and Aspergillus in multiple in vitro studies and clinical trials. Garlic-derived ajoene achieved 100% mycological cure in tinea pedis in a randomized double-blind trial. Diallyl disulfide depletes glutathione in Candida albicans, and fresh garlic extract inhibits Aspergillus species. Garlic's dermatophytic use is recognized in peer-reviewed dermatology literature.

Garlic demonstrates broad antifungal activity against dermatophytes (Trichophyton spp.) and Candida in vitro. Topical garlic creams have shown efficacy comparable to standard antifungals for skin dermatophyte infections. Allicin and ajoene are the primary active antifungal agents.

Multiple in vitro studies confirm that geranium EO has significant antifungal activity against Candida species, dermatophytes causing athlete's foot, and Malassezia causing skin disease. Laboratory evidence is strong. Human clinical trials for topical antifungal use have not been conducted.

The 2019 PMC systematic review confirms antifungal properties of G. littoralis extracts as one of the documented pharmacological activities. Active compounds including polyacetylenes and coumarins are implicated. No human clinical trials specific to fungal skin conditions have been conducted.

In vitro studies published in PubMed/PMC demonstrate that isothiocyanates extracted from horseradish root inhibit growth of four pathogenic dermal fungi (Trichophyton rubrum, T. mentagrophytes, Microsporum canis, Epidermophyton floccosum) with MIC values of 100–200 µg/mL. ITCs were more active against fungi than bacteria in comparative assays. Evidence is in vitro only; no human clinical trials.

H. italicum EO and extracts demonstrate antifungal activity against Candida albicans and other fungi in vitro. Acetophenones, phloroglucinols, and terpenoids contribute to this activity. Multiple studies across different laboratories have confirmed antifungal MIC values approaching or matching clinical reference antifungal agents.

Impatiens balsamina possesses documented antifungal activity in vitro against multiple clinically relevant fungal species including Trichophyton and Candida. Antimicrobial peptides Ib-AMP1 and Ib-AMP4 derived from I. balsamina have been studied as antifungal agents. Traditional use for fungal skin and nail conditions spans Chinese, Thai, and Native American medicine.

In vitro studies demonstrate antifungal activity of Indigofera species extracts against Candida albicans and other fungi. The EBSCO Research Starters source cites a test-tube trial showing 'significant activity against certain bacteria and fungi.' This is preclinical scientific evidence; no human trials exist.

Lauric acid, a medium-chain fatty acid abundant in coconut oil, has demonstrated antifungal activity against Candida species by disrupting fungal cell membranes. Monolaurin (the monoglyceride of lauric acid) is specifically active against Candida albicans and Malassezia. Coconut oil, primarily through its lauric acid content, has in vitro and one small clinical trial showing activity against C. albicans in cutaneous candidiasis.

Lavender essential oil has demonstrated potent antifungal activity against dermatophytes (tinea-causing fungi) and Candida species in multiple laboratory studies, with membrane disruption as the proposed mechanism. University of Coimbra research confirmed lavender oil is lethal to multiple skin-pathogenic fungal strains. This positions it as a scientifically-supported topical antifungal agent, though human trial data are limited.

A clinical pilot study showed topical LGEO was effective for pityriasis versicolor (a fungal skin disease caused by Malassezia), with mycological cure demonstrated in vivo, though less effective than ketoconazole. LGEO also demonstrated in vitro activity against dermatophytes responsible for tinea infections. A 2024 scoping review confirmed pityriasis versicolor as one of the substantiated clinical applications of LGEO.

Limonene has documented in vitro antifungal activity relevant to dermatophytes and skin-associated fungi. Studies specifically evaluate activity against experimentally induced dermatomycosis in rat models. Its well-characterized membrane-disrupting antifungal mechanism applies to cutaneous fungal pathogens. Evidence remains primarily preclinical and in vitro.

In vitro studies confirm mangosteen xanthones have antifungal activity. Drugs.com and MSKCC cite antibacterial and antifungal properties among documented biological activities of mangosteen xanthones. Traditional use also includes treatment of thrush and skin fungal conditions with pericarp preparations.

Marjoram essential oil and extracts have documented antifungal activity in multiple in vitro studies, active against dermatologically relevant fungal species. This activity is attributed to terpinen-4-ol and related terpene compounds.

Tea tree oil from Melaleuca alternifolia has demonstrated in vitro antifungal activity against dermatophytes (Trichophyton rubrum, T. mentagrophytes, T. tonsurans), Candida albicans, and Malassezia furfur. Clinical trials show it reduces symptoms of tinea pedis, though it does not always achieve mycological cure equivalent to conventional antifungals. Its main active antifungal component is terpinen-4-ol, which disrupts fungal membrane integrity.

Monolaurin, the monoglyceride of lauric acid derived from coconut oil, has documented antifungal activity against Candida species and other skin-infecting fungi by disrupting the lipid bilayer of fungal cell membranes. It is the biologically active antimicrobial form of lauric acid. In vitro studies confirm its activity against C. albicans, and it has GRAS status from the FDA.

A. vulgaris essential oil demonstrates in vitro antifungal activity relevant to skin pathogens, and the plant is used in CosIng-recognized cosmetic formulations. Multiple preclinical studies confirm activity against Candida albicans and bacterial skin pathogens. Evidence is preclinical and cosmetic; no clinical dermatological antifungal trials exist.

In vitro studies (including a PMC 2024 study) demonstrate that neem leaf ethanolic extract inhibits the growth of dermatophytes Microsporum canis and Trichophyton tonsurans, the principal causes of tinea infections. A. indica extracts also suppress Candida, Trichosporon, Geotrichum, and Epidermophyton. Terpenoids including azadirachtin are the primary antifungal constituents.

OA has preclinically demonstrated antifungal activity relevant to skin fungal infections, including against dermatophytes, as part of its broader antimicrobial activity profile. This is supported by in vitro and limited animal evidence.

Orange essential oil and peel extracts demonstrate documented antifungal activity. The oil is used industrially as an antifungal agent in food preservation, and laboratory studies confirm activity against multiple fungal species. In vitro antifungal evidence is robust; clinical trial evidence in humans for skin fungal infections is limited.

Oregano (Origanum vulgare) essential oil contains carvacrol and thymol as its primary active antifungal components and has demonstrated potent in vitro antifungal activity, including complete inhibition of C. albicans at 0.25 mg/mL and activity against all Candida isolates tested. Oregano essential oil was found to be the most powerful of 11 essential oils tested against athlete's foot-causing bacteria in a comparative study. Its activity extends to drug-resistant and biofilm-forming Candida strains.

M. aquifolium extracts and isolated berberine/jatrorrhizine demonstrate in vitro antifungal activity against Trichophyton dermatophytes, Candida species, and Malassezia associated with pityriasis versicolor and seborrheic dermatitis. The evidence is in vitro; no published RCTs exist for Oregon grape in clinical dermatophyte infections such as athlete's foot.

Berberine and palmatine from P. amurense have demonstrated antifungal activity against dermatophytes including Microsporum canis in animal models, and P. amurense methanol extract significantly inhibited multiple Candida species in vitro. An animal study showed combined berberine and palmatine treatment was effective against Microsporum canis-induced dermatitis in rabbits. P. amurense has been used in TCM for fungal skin conditions including athlete's foot and ringworm.

In vitro evidence (Bafi-Yeboa et al., 2005) confirms broad-spectrum antifungal activity of Z. americanum extracts, which was recognized as providing 'a phytochemical basis for the very widespread use of Z. americanum in indigenous North American ethnomedical tradition for conditions that may be related to fungal infections.' Traditional use for skin infections is documented. No human trials exist.

Propolis, a resinous bee-derived substance, has demonstrated antifungal activity against Candida species, Trichophyton mentagrophytes, T. tonsurans, and other dermatophytes in multiple in vitro studies. A PMC study (Frontiers in Microbiology 2018) assessed ethanol propolis extract for onychomycosis from bench to clinical application with positive antifungal outcomes. Brazilian red propolis shows activity against Trichophyton species responsible for dermatophytosis. Its antifungal components include flavonoids, terpenoids, and phenolic compounds.

Z. bungeanum leaf and pericarp fractions show significant antifungal activity against multiple pathogenic and food-spoilage fungi in vitro, including drug-resistant Candida albicans. The volatile essential oil demonstrates fungistatic effects. TCM also uses it externally for skin fungal conditions.

Antifungal activity of Swertia chirayita extracts is documented in peer-reviewed studies. The plant is an ingredient in the marketed antifungal ointment Melicon V. Multiple pharmacological reviews confirm antifungal activity as a pharmacologically validated property.

Thymol, a naturally occurring phenolic compound found in oregano, thyme, and other plants, has documented broad-spectrum antifungal activity. It is one of the two principal antifungal components of oregano and thyme oils (alongside carvacrol). A PMC 2025 review confirmed thymol's wide-spectrum antifungal activities, including against Candida biofilms and multidrug-resistant C. albicans. Thymol inhibits fungal cell membranes and is active against skin-infecting fungi including Malassezia.

Thymus vulgaris essential oil and thymol have demonstrated antifungal activity in vitro against dermatophytes, Candida species, and other pathogenic fungi relevant to skin infections. Studies confirm activity against germ tube formation, preformed biofilms, and fungal strains resistant to fluconazole. Evidence is in vitro; no clinical trials for fungal skin conditions specifically have been published.

Turmeric (Curcuma longa) and its ar-turmerone-rich oil have demonstrated antifungal activity against dermatophytes, particularly Trichophyton rubrum, in vitro and in formulated creams. A PMC study confirmed that 6% w/w turmeric cream is effective against dermatophytes and suitable as an alternative antidermatophytic preparation. Traditional use for tinea and ringworm in Ayurvedic and Southeast Asian medicine is substantiated by this ethnopharmacological evidence.

Essential oil from X. strumarium leaves demonstrated potent antifungal activity against multiple fungal strains in validated laboratory testing. Extracts have also shown broad antibacterial and antifungal effects in several in vitro studies. Traditional use for skin fungal conditions is documented across Indian and African ethnomedicine.

Antifungal activity of Zanthoxylum has been demonstrated in multiple laboratory studies against dermatophytes and Candida species. Z. caribaeum bark is traditionally used for fungal skin infections. Coumarins from Zanthoxylum have established antifungal properties. Evidence is largely in vitro.

Zinc has established antifungal properties and is a core component of FDA-approved topical antifungal formulations (zinc undecylenate). It supports immune defense against fungal infections and inhibits Candida morphogenesis in vitro. Zinc pyrithione is widely used in antifungal/anti-dandruff products targeting Malassezia. Zinc deficiency is associated with increased susceptibility to cutaneous fungal infections.

A. galanga has documented in vitro antifungal activity against dermatophytes relevant to skin infections. Traditional systems use it for skin diseases including fungal conditions and tinea. Antifungal cream formulations using galangal extract have been developed and studied in pharmacy research.

ACV has been widely used topically in folk medicine for fungal skin conditions, including tinea and dandruff, on the basis of its acidic pH and in vitro antifungal activity. No human RCTs have validated topical ACV for fungal skin conditions specifically. Dermatologist recommendation for dilute ACV soaks is common but evidence-based support is limited.

Cassia bark essential oil and extracts demonstrate broad antifungal activity against dermatophytes and Candida in vitro. Topical use for skin fungal conditions is documented in traditional medicine. Clinical evidence specifically for topical skin fungal conditions in humans is not established in the peer-reviewed literature reviewed.

TCM texts list coix seed for athlete's foot (tinea pedis) and dampness-related skin fungal conditions. The seed's antimicrobial properties, documented in laboratory studies, include some antifungal activity, though specific human clinical trials for fungal skin infections are lacking.

TCM documents Coptis chinensis use for fungal skin conditions including tinea pedis (athlete's foot) and skin infections. Berberine's antifungal activity against dermatophytes is supported by in vitro data. Classical texts list the herb for dermatological diseases including tinea and skin infections.

E. purpurea has traditional use for fungal skin and urogenital infections, supported by early clinical reports and in vitro evidence of antifungal activity against clinically isolated fungi. Controlled clinical trial evidence is limited and of questionable validity by modern standards.

Goldenrod contains antifungal saponins documented to have activity against Candida albicans in vitro. Traditional herbal practice uses goldenrod topically and as washes for fungal skin conditions. The antifungal saponins are described as useful for oral and vaginal thrush when applied locally. In vitro evidence supports antifungal activity, but no human skin trials exist.

Goldenseal's berberine content confers antifungal activity demonstrated in vitro, and the herb is traditionally used for fungal skin conditions. The NCCIH notes berberine has been used traditionally against bacteria, fungi, and viruses.

Ho wood essential oil is traditionally used to combat fungal infections of the skin, attributed to linalool's antifungal activity. In vitro evidence supports linalool's antifungal efficacy against Candida, Aspergillus, Fusarium, and other fungi.

H. antidysenterica is listed as antifungal in Ayurvedic practice and used topically for fungal skin conditions. Phytochemical reviews cite antifungal activity among its documented pharmacological properties. Formal in vitro antifungal susceptibility data and clinical trials are limited in peer-reviewed literature.

Indian sarsaparilla is used in Ayurvedic tradition for ringworm and fungal skin infections, applied as a topical paste. Antimicrobial activity against multiple organisms has been documented in preclinical studies, though specific antifungal clinical trials are absent.

P. orientalis is traditionally used for fungal skin conditions including Tinea (ringworm), documented in the systematic review literature. Preclinical studies demonstrate fungistatic and antifungal activity of essential oils and extracts. The plant is used in traditional medicine for parasitic skin diseases.

Pau d'arco (Tabebuia species) bark has been used traditionally in South American indigenous medicine for centuries to treat fungal and yeast skin infections. Its active naphthoquinone compounds, particularly lapachol and beta-lapachone, have shown antifungal activity against Candida and other fungi in vitro. Traditional use for skin mycoses remains widespread in Brazilian and Andean ethnomedicine, though rigorous clinical RCTs for cutaneous fungal infections are lacking.

Quillaja saponins exhibit documented in vitro antifungal activity against multiple fungal species, and the bark has traditional topical use for scalp conditions associated with fungal overgrowth. The antifungal mechanism involves disruption of fungal cell membranes via cholesterol complexation. Evidence is preclinical and traditional, not from human skin trials.

Sophora flavescens (Ku Shen) is traditionally used for fungal skin infections including tinea and scabies. TCM texts document its use for boils, fungal infections, and oozing sores. Preclinical antifungal activity has been demonstrated against multiple fungal pathogens.

A. muricata leaves are traditionally used to treat skin diseases and skin rashes across tropical Africa and South America. The documented antifungal activity in vitro and traditional topical use of leaves provide combined support.

Thyme essential oil has documented in vitro antifungal activity against dermatophytes and Candida species relevant to skin fungal infections. Traditional European herbal medicine has used diluted thyme oil topically for nail and skin fungal infections for centuries. A naturimedica resource citing pharmacopoeia context specifically notes its application for toenail fungal infections.